ZA863578B - Dihydropyridine derivatives - Google Patents

Dihydropyridine derivatives

Info

Publication number
ZA863578B
ZA863578B ZA863578A ZA863578A ZA863578B ZA 863578 B ZA863578 B ZA 863578B ZA 863578 A ZA863578 A ZA 863578A ZA 863578 A ZA863578 A ZA 863578A ZA 863578 B ZA863578 B ZA 863578B
Authority
ZA
South Africa
Prior art keywords
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
ZA863578A
Other languages
English (en)
Inventor
Roland Jaunin
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA863578B publication Critical patent/ZA863578B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA863578A 1985-06-21 1986-05-14 Dihydropyridine derivatives ZA863578B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH265185 1985-06-21

Publications (1)

Publication Number Publication Date
ZA863578B true ZA863578B (en) 1987-02-25

Family

ID=4238542

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA863578A ZA863578B (en) 1985-06-21 1986-05-14 Dihydropyridine derivatives

Country Status (6)

Country Link
US (2) US4847273A (ja)
EP (1) EP0212107A1 (ja)
JP (1) JPS62466A (ja)
AU (1) AU5899386A (ja)
DK (1) DK224786A (ja)
ZA (1) ZA863578B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61293972A (ja) * 1985-06-24 1986-12-24 Nisshin Flour Milling Co Ltd １，４−ジヒドロピリジンスルホン誘導体およびその製法
WO1993006082A1 (en) * 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5310917A (en) * 1991-09-13 1994-05-10 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropydrines
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
CN104211621B (zh) * 2014-08-07 2016-05-25 中国农业大学 一种环烷基磺酰胺类化合物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH607848A5 (ja) * 1974-06-04 1978-11-30 Bayer Ag
DE2616995A1 (de) * 1976-04-17 1977-10-27 Bayer Ag 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3323510A1 (de) * 1983-06-30 1985-01-10 Hoechst Ag, 6230 Frankfurt 2-ketosulfonamide und verfahren zu deren herstellung
DE3323511A1 (de) * 1983-06-30 1985-01-10 Hoechst Ag, 6230 Frankfurt 2-keto-sulfonamide und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS62466A (ja) 1987-01-06
DK224786D0 (da) 1986-05-14
US4994612A (en) 1991-02-19
AU5899386A (en) 1986-12-24
DK224786A (da) 1986-12-22
US4847273A (en) 1989-07-11
EP0212107A1 (de) 1987-03-04

Similar Documents

Publication Publication Date Title
EP0191562A3 (en) Tetrahydrocarbazolone derivatives
GB8620638D0 (en) Derivatives
GB2162513B (en) Dihydropyridine derivatives
GB8601292D0 (en) 13beta-alkylmilbemycin derivatives
GB8617292D0 (en) Poly-4-aminopyyrrole-2-carboxamido derivatives
GB2176181B (en) Aryltetralin derivatives
GB8614176D0 (en) Piperonylcarboxamido derivatives
GB2174703B (en) Pyridinylpiperazine derivatives
GB2172286B (en) Tetraprenylamine derivatives
GB2177692B (en) Diazinylpiperidine derivatives
GR860384B (en) Antihypertensive dihydropyridine derivatives
ZA86966B (en) Antihypertensive dihydropyridine derivatives
GB8623513D0 (en) Glucosylmoranoline derivatives
ZA863578B (en) Dihydropyridine derivatives
PH22683A (en) Dihydropyridine derivatives
AU5326186A (en) Dihydropyridine derivatives
GB8520631D0 (en) Derivatives
GB8623075D0 (en) Bicyclocatechol derivatives
GB8511892D0 (en) Fluoralkane derivatives
GB2177695B (en) Aminoalkylamide derivatives
GB8600575D0 (en) Benzonorbornene derivatives
GB2177090B (en) 10-alpha-methoxy-6-methyl-ergoline derivatives
GB2174092B (en) Eburnamenine derivatives
PH21510A (en) Dihydropyridine derivatives
IE851483L (en) Dihydropyridine derivatives